These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2965680)
1. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Baker PJ; Hiernaux JR; Fauntleroy MB; Prescott B; Cantrell JL; Rudbach JA Infect Immun; 1988 May; 56(5):1076-83. PubMed ID: 2965680 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice. Hiernaux JR; Stashak PW; Cantrell JL; Rudbach JA; Baker PJ Infect Immun; 1989 May; 57(5):1483-90. PubMed ID: 2707856 [TBL] [Abstract][Full Text] [Related]
3. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers. Vernacchio L; Bernstein H; Pelton S; Allen C; MacDonald K; Dunn J; Duncan DD; Tsao G; LaPosta V; Eldridge J; Laussucq S; Ambrosino DM; Molrine DC Vaccine; 2002 Nov; 20(31-32):3658-67. PubMed ID: 12399193 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides. Baker PJ; Taylor CE; Stashak PW; Fauntleroy MB; Hasløv K; Qureshi N; Takayama K Infect Immun; 1990 Sep; 58(9):2862-8. PubMed ID: 2143752 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide. Baker PJ; Fauntleroy MB; Stashak PW; Hiernaux JR; Cantrell JL; Rudbach JA Infect Immun; 1989 Mar; 57(3):912-7. PubMed ID: 2783922 [TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of the immune response to pneumococcal polysaccharides]. Rodionychev EA Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):103-8. PubMed ID: 2936046 [No Abstract] [Full Text] [Related]
7. Ability of monophosphoryl lipid A to augment the antibody response of young mice. Baker PJ; Hiernaux JR; Fauntleroy MB; Stashak PW; Prescott B; Cantrell JL; Rudbach JA Infect Immun; 1988 Dec; 56(12):3064-6. PubMed ID: 2972626 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice. Ekwunife FS; Taylor CE; Fauntleroy MB; Stashak PW; Baker PJ Infect Immun; 1991 Jun; 59(6):2192-4. PubMed ID: 1828058 [TBL] [Abstract][Full Text] [Related]
9. The role of antigen in the activation of regulatory T cells by immune B cells. Baker PJ; Taylor C; Fauntleroy MB; Stashak PW; Prescott B Cell Immunol; 1985 Dec; 96(2):376-85. PubMed ID: 2943420 [TBL] [Abstract][Full Text] [Related]
10. Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A. Baker PJ; Haslov KR; Fauntleroy MB; Stashak PW; Myers K; Ulrich JT Infect Immun; 1990 Mar; 58(3):726-31. PubMed ID: 1968433 [TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity of pertussis toxin is mediated by differential effects on the activity of T suppressor, T amplifier and T helper cells. Hasløv K; Petersen JW; Baker PJ Immunobiology; 1991 Sep; 183(1-2):40-54. PubMed ID: 1834545 [TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A. Esquivel F; Taylor CE; Baker PJ Infect Immun; 1991 Sep; 59(9):2994-8. PubMed ID: 1831794 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. Schneerson R; Fattom A; Szu SC; Bryla D; Ulrich JT; Rudbach JA; Schiffman G; Robbins JB J Immunol; 1991 Oct; 147(7):2136-40. PubMed ID: 1918948 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B Rev Infect Dis; 1981; 3(2):332-41. PubMed ID: 6973183 [TBL] [Abstract][Full Text] [Related]
15. The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice. Kearney R; Andrews J; Johnstone S Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():19-35. PubMed ID: 2938567 [TBL] [Abstract][Full Text] [Related]
16. T-cell modulation of the antibody response to bacterial polysaccharide antigens. Taylor CE; Bright R Infect Immun; 1989 Jan; 57(1):180-5. PubMed ID: 2462536 [TBL] [Abstract][Full Text] [Related]
17. Regulation of IgG responses by helper and suppressor T cells activated by pneumococcal capsular polysaccharides. Milligan GN; Braley-Mullen H Cell Immunol; 1989 Mar; 119(1):222-32. PubMed ID: 2465833 [TBL] [Abstract][Full Text] [Related]
18. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response. Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533 [TBL] [Abstract][Full Text] [Related]
19. Requirements for activation of contrasuppressor T cells by type III pneumococcal polysaccharide. Braley-Mullen H J Immunol; 1986 Jan; 136(2):396-401. PubMed ID: 2867113 [TBL] [Abstract][Full Text] [Related]
20. Examination of the differential characteristics of amplifier and contrasuppressor T cells. Baker PJ; Fauntleroy MB; Prescott B Immunobiology; 1988 Sep; 177(4-5):438-48. PubMed ID: 2904409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]